Return to Article Details
EVALUATION OF FACTORS ASSOCIATED WITH TREATMENT OUTCOME OF ADJUVANT DOCETAXEL-CARBOPLATIN-TRASTUZUMAB REGIMEN IN HER2/NEU POSITIVE BREAST CANCER
Download
Download PDF